EUVIMEDEUVIMED entdecken
Open Access

A Novel Platform for Fast and Cost‐Effective Screening of Immunomodulatory Compounds

Suzana Lj Popovic iD, Dejan D Baskic, Marina M Mitrovic, Sanja D Matic, Tijana R Markovic, Marijana S Stanojevic Pirkovic iD, Mirela M Jevtic, Ivana Z Lazic, Danijela V Todorovic

Advanced Biology · 2026

DOI: 10.1002/adbi.202500696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Biology, 2026. Verfasst von Suzana Lj Popovic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia. Hauptthemen laut MEDLINE: Leukocytes, Mononuclear, Immunologic Factors, Immunomodulating Agents. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Compounds with immunomodulatory properties are increasingly recognized as valuable adjunctive therapies in pathological conditions associated with immune dysregulation. However, their discovery process is often costly and time‐consuming. The aim of this study is to develop a low‐cost, simple‐to‐perform, and reliable method for screening immunomodulatory agents. Human peripheral blood mononuclear cells (PBMNCs) are used as a model system. PBMNCs are isolated by density gradient centrifugation and treated with different immunostimulators and immunosuppressors. By measuring several analytes with a gas analyzer, it is revealed that changes in lactate levels alone can be used as an indicator of immune cell activation/suppression. This finding is further confirmed by measuring the expression of cell surface activation markers and HIF1α using flow cytometry, glucose concentration in PBMNC cultures using a gas analyzer, and levels of TNF‐ά and IL‐10 by ELISA. The results presented here reveal the simplicity and reliability of this innovative platform for screening immunomodulatory compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukocytes, MononuclearImmunologic FactorsImmunomodulating AgentsHumansFlow CytometryCost-Benefit AnalysisDrug Evaluation, PreclinicalTumor Necrosis Factor-alphaInterleukin-10Lactic AcidCells, Cultured

Stichwörter der Autor:innen

PBMNCassayimmunomodulationlactate

Substanzen

Immunologic FactorsImmunomodulating AgentsTumor Necrosis Factor-alphaInterleukin-10Lactic Acid

Autor:innen und Institutionen

  • Centre for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
  • Institute of Public Health Kragujevac, Kragujevac, Serbia.
  • Department of Medical Biochemistry, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
  • Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
  • Department of Laboratory Diagnostics, University Clinical Center Kragujevac, Kragujevac, Serbia.
  • Department of Gynecology and Obstetrics, General Hospital Uzice, Uzice, Serbia.

ORCID-Profile: Suzana Lj Popovic, Marijana S Stanojevic Pirkovic

Zitieren

APA

Popovic, S. L., Baskic, D. D., Mitrovic, M. M., Matic, S. D., Markovic, T. R., Pirkovic, M. S. S., Jevtic, M. M., Lazic, I. Z., & Todorovic, D. V. (2026). A Novel Platform for Fast and Cost‐Effective Screening of Immunomodulatory Compounds. Advanced Biology. https://doi.org/10.1002/adbi.202500696

Vancouver

Popovic SL, Baskic DD, Mitrovic MM, Matic SD, Markovic TR, Pirkovic MSS, et al. A Novel Platform for Fast and Cost‐Effective Screening of Immunomodulatory Compounds. Advanced Biology. 2026. doi:10.1002/adbi.202500696

BibTeX
@article{Popovic2026,
  author = {Popovic, Suzana Lj and Baskic, Dejan D and Mitrovic, Marina M and Matic, Sanja D and Markovic, Tijana R and Pirkovic, Marijana S Stanojevic and Jevtic, Mirela M and Lazic, Ivana Z and Todorovic, Danijela V},
  title = {A Novel Platform for Fast and Cost‐Effective Screening of Immunomodulatory Compounds},
  journal = {Advanced Biology},
  year = {2026},
  doi = {10.1002/adbi.202500696}
}
Kostenlos starten →